He entered Istanbul University Cerrahpaşa Faculty of Medicine in 1987 and started his compulsory service in Akçaabat district of Trabzon in 1993. In January 1995, he was admitted to the Hepato-Biliary Surgery service of the Universite Libre Bruxelles Erasmus Hospital in Brussels, Belgium. He started his General Surgery residency in October 1996 and became a General Surgery Specialist in Belgium in 2002 with the thesis "Le Re-do Gastroplastie dans le traitement des complications des Procedure Bariatriques pour Obesité Morbide" (Revision Surgery in the Treatment of Complications of Bariatric Procedures for Morbid Obesity).
He worked in the Hepatobiliary Surgery service of ULB Erasmus Hospital until October 2003, and then in October 2003 he joined Providence Hospital in Neuchatel, Switzerland as Deputy Chief of Surgery Clinic. In March 2004, he was appointed as Chief of Surgery Clinic at Neuchatel Hospital Cadolles Pourtales NHP and played an important role in Advanced Laparoscopic Surgery, Bariatric Surgery, Oncologic Surgery, Traumatology, Vascular and Thoracic Surgery and resident training.
He started his career in the private sector by obtaining equivalency in the field of General Surgery at Çukurova University. He is currently serving as a General Surgery Specialist at NPISTANBUL Hospital.
Areas of Interest:
He entered Istanbul University Cerrahpaşa Faculty of Medicine in 1987 and started his compulsory service in Akçaabat district of Trabzon in 1993. In January 1995, he was admitted to the Hepato-Biliary Surgery service of the Universite Libre Bruxelles Erasmus Hospital in Brussels, Belgium. He started his General Surgery residency in October 1996 and became a General Surgery Specialist in Belgium in 2002 with the thesis "Le Re-do Gastroplastie dans le traitement des complications des Procedure Bariatriques pour Obesité Morbide" (Revision Surgery in the Treatment of Complications of Bariatric Procedures for Morbid Obesity).
He worked in the Hepatobiliary Surgery service of ULB Erasmus Hospital until October 2003, and then in October 2003 he joined Providence Hospital in Neuchatel, Switzerland as Deputy Chief of Surgery Clinic. In March 2004, he was appointed as Chief of Surgery Clinic at Neuchatel Hospital Cadolles Pourtales NHP and played an important role in Advanced Laparoscopic Surgery, Bariatric Surgery, Oncologic Surgery, Traumatology, Vascular and Thoracic Surgery and resident training.
He started his career in the private sector by obtaining equivalency in the field of General Surgery at Çukurova University. He is currently serving as a General Surgery Specialist at NPISTANBUL Hospital.
Areas of Interest:
Medical Interests
Interventional Bronchoscopy
Respiratory Deficiencies
Rare diseases of the lung
Interstitial lung diseases
Psychoneuroimmunology
Medical Fitness and nutrition
Education
Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997
Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Experience
Dr. / Ayazağa MCHFP / 1997-2001
Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006
Res. See. / Hopital St-Marguerite Center Laser / 2004
Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005
Dr. / Bozüyük State Hospital / 2006-2008
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012
Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012
Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017
Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018
Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital
Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021
Liv Hospital Vadistanbul / 2021 -
Memberships
European Respiratory Society (ERS)
European Association of Bronchology and Interventional Pulmonology (EABIP)
Societé de Pnemologie de langue Française (SPLF)
Groupe d’Endoscopie de langue française (GELF)
Read moreMedical Interests
Interventional Bronchoscopy
Respiratory Deficiencies
Rare diseases of the lung
Interstitial lung diseases
Psychoneuroimmunology
Medical Fitness and nutrition
Education
Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997
Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Experience
Dr. / Ayazağa MCHFP / 1997-2001
Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006
Res. See. / Hopital St-Marguerite Center Laser / 2004
Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005
Dr. / Bozüyük State Hospital / 2006-2008
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012
Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012
Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017
Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018
Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital
Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021
Liv Hospital Vadistanbul / 2021 -
Memberships
European Respiratory Society (ERS)
European Association of Bronchology and Interventional Pulmonology (EABIP)
Societé de Pnemologie de langue Française (SPLF)
Groupe d’Endoscopie de langue française (GELF)
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Read more
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Prof. Dr. Emre Şeker is a renowned dental specialist with a distinguished academic career and extensive clinical experience. As the founder of Dentarma Dental Clinic, he combines his expertise with a patient-centered approach to deliver exceptional dental care.
Prof. Dr. Şeker holds a Ph.D. in Prosthodontics and has served as an Associate Professor at esteemed universities in Turkey. His academic background, coupled with his hands-on clinical practice, positions him as a leading authority in the field of implant dentistry, smile design, and advanced prosthetic treatments.
With a focus on patient satisfaction and utilizing cutting-edge technology, Prof. Dr. Emre Şeker and his team at Dentarma are committed to providing world-class dental solutions.
Key Areas of Expertise:
Prof. Dr. Emre Şeker is a renowned dental specialist with a distinguished academic career and extensive clinical experience. As the founder of Dentarma Dental Clinic, he combines his expertise with a patient-centered approach to deliver exceptional dental care.
Prof. Dr. Şeker holds a Ph.D. in Prosthodontics and has served as an Associate Professor at esteemed universities in Turkey. His academic background, coupled with his hands-on clinical practice, positions him as a leading authority in the field of implant dentistry, smile design, and advanced prosthetic treatments.
With a focus on patient satisfaction and utilizing cutting-edge technology, Prof. Dr. Emre Şeker and his team at Dentarma are committed to providing world-class dental solutions.
Key Areas of Expertise:
Dr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.
Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.
Post-Specialization Trainings:
2003, Gazi University Faculty of Medicine, MRI Department, Ankara
2003, Marmara University Faculty of Medicine, MRI Department, Istanbul
2001-2004, ESNR European Course of Neuroradiology (3 Semesters)
1997, Johns Hopkins University, Neuroradiology, Baltimore, USA
1997, Cornell University, Neuroradiology, New York, USA
1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul
1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir
1993, Uludağ University Faculty of Medicine, MRI Department, Bursa
1993, UCLA Medical Center (as visitor), Los Angles, USA
1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul
His Academic Studies:
International Publications: 23
International Papers: 27
National Publications: 45
National Papers: 48
Conferences: 11
Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences
Scientific Organizations he is a member of:
European Society of Radiology (ESR)
Turkish Radiology Association (TRD)
Magnetic Resonance Association
Istanbul Medical Chamber (ITO)
Turkish Neuroradiology Association
In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.
In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”
His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.
As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.
He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.
Read moreDr Ozates was born in 1966 in Birecik district of Sanliurfa in Turkey. He completed his primary and secondary education in my hometown, Birecik. He got into Istanbul University Istanbul Faculty of Medicine in 1983. After 6 years of successful education, he started Radiology education at Dicle University Faculty of Medicine by passing the Medical Specialization Examination (TUS) in the same year I graduated in 1989.
Between 1993 and 1995, he worked as a Radiology Specialist in various hospitals in Gaziantep. He passed the Assistant Professorship exam and started to work as a faculty member at Dicle University in 1995.
Post-Specialization Trainings:
2003, Gazi University Faculty of Medicine, MRI Department, Ankara
2003, Marmara University Faculty of Medicine, MRI Department, Istanbul
2001-2004, ESNR European Course of Neuroradiology (3 Semesters)
1997, Johns Hopkins University, Neuroradiology, Baltimore, USA
1997, Cornell University, Neuroradiology, New York, USA
1996, Istanbul University Faculty of Medicine, MRI Department, Istanbul
1994, Dokuz Eylül University Faculty of Medicine, MRI Department, İzmir
1993, Uludağ University Faculty of Medicine, MRI Department, Bursa
1993, UCLA Medical Center (as visitor), Los Angles, USA
1992-1993, Maçka EMAR, Dr. Murat Dinçer, Istanbul
His Academic Studies:
International Publications: 23
International Papers: 27
National Publications: 45
National Papers: 48
Conferences: 11
Citations: 210 Scientific Publications (Average Citations per Item: 10.50, h-index: 9), USA edition 1 Book, Various Conferences
Scientific Organizations he is a member of:
European Society of Radiology (ESR)
Turkish Radiology Association (TRD)
Magnetic Resonance Association
Istanbul Medical Chamber (ITO)
Turkish Neuroradiology Association
In 2003, he was awarded the title of Associate Professor with the examination held at Marmara University Faculty of Medicine. In 2005-2013, Dr. Lütfi Kırdar Kartal Training and Research Hospital Radiology Clinic Chief, Training and Administrative Officer.
In 2013, he started to work as a professor at Nişantaşı University. On March 15, 2013, he was appointed as the Inter-University Board Representative for 1 year. He is a Member of the Board of Trustees of Ayvansaray University. He is a sub – specialist in “Pediatric Radiology”
His articles have been published in many magazines in Turkey and abroad. He presented written and oral presentations and gave conferences at congresses in various cities and countries.
As the Radiology Clinic Chief of Bağcılar Training and Research Hospital, he is the first professor who performed Coronary CT Angiography in a state hospital in Istanbul.
He is one of Turkey’s first Children’s Radiology Specialist Minor. He did his military service between March and April 2000 at the 200-bed Malatya Military Hospital.
AREAS OF INTEREST
Radial Angiography
Complex coronary interventions
Intracoronary examinations (FFR, IVUS, OCT)
Calcific lesion treatments (Rotablator, shockwave balloon )
Chronic total occlusion attempts
Transcatheter Aortic valve implantations (TAVI)
Aortic interventions
Mitral valve attempts
Peripheral arterial interventions
ASD/PFO/VSD closure
LAA closure
Paravalvuler closure
Carotid arterial interventions
Septal ablation
Pulmonary embolism interventions
Education
Cerrahpaşa Faculty of Medicine
Istanbul University Institute of Cardiology
Royal Brompton Hospital (London)
Experience
Istanbul University Institute of Cardiology
Turkish Kidney Foundation Service Hospital
Istanbul University Institute of Cardiology
Royal Brompton Hospital
University of Health Sciences Şişli Hamidiye Etfal Hospital (founding chief)
University of Health Sciences Prof. Dr. Cemil Taşçıoğlu city hospital (founding chief)
LIV Hospital Ulus
Memberships
Turkish Society of Cardiology
European Society of Cardiolog
Read moreAREAS OF INTEREST
Radial Angiography
Complex coronary interventions
Intracoronary examinations (FFR, IVUS, OCT)
Calcific lesion treatments (Rotablator, shockwave balloon )
Chronic total occlusion attempts
Transcatheter Aortic valve implantations (TAVI)
Aortic interventions
Mitral valve attempts
Peripheral arterial interventions
ASD/PFO/VSD closure
LAA closure
Paravalvuler closure
Carotid arterial interventions
Septal ablation
Pulmonary embolism interventions
Education
Cerrahpaşa Faculty of Medicine
Istanbul University Institute of Cardiology
Royal Brompton Hospital (London)
Experience
Istanbul University Institute of Cardiology
Turkish Kidney Foundation Service Hospital
Istanbul University Institute of Cardiology
Royal Brompton Hospital
University of Health Sciences Şişli Hamidiye Etfal Hospital (founding chief)
University of Health Sciences Prof. Dr. Cemil Taşçıoğlu city hospital (founding chief)
LIV Hospital Ulus
Memberships
Turkish Society of Cardiology
European Society of Cardiolog
Read more
Education:
Medical Degree: Çukurova University Faculty of Medicine (1993)
Specialization in Urology: Şişli Etfal Training and Research Hospital (2005)
Professional Experience:
Current Position: Practicing at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul
Past Experience: Extensive work in both public and private healthcare sectors, including significant contributions at Istanbul İstinye University Health Practice and Research Center.
Areas of Interest:
Pediatric Urology
Urogynecology
Treatment of pediatric urology disorders
Urological surgeries and procedures
Professional Memberships:
Member of several prestigious medical societies, including the Turkish Medical Association, European Society of Pediatric Urology, and the Turkish Society of Pediatric Urology.
Certifications:
Dr. Güllüoğlu has completed numerous certifications and advanced training programs, reflecting his commitment to continuous professional development and staying at the forefront of urological advancements.
Read moreEducation:
Medical Degree: Çukurova University Faculty of Medicine (1993)
Specialization in Urology: Şişli Etfal Training and Research Hospital (2005)
Professional Experience:
Current Position: Practicing at İstinye University Hospital Medical Park Gaziosmanpaşa, Istanbul
Past Experience: Extensive work in both public and private healthcare sectors, including significant contributions at Istanbul İstinye University Health Practice and Research Center.
Areas of Interest:
Pediatric Urology
Urogynecology
Treatment of pediatric urology disorders
Urological surgeries and procedures
Professional Memberships:
Member of several prestigious medical societies, including the Turkish Medical Association, European Society of Pediatric Urology, and the Turkish Society of Pediatric Urology.
Certifications:
Dr. Güllüoğlu has completed numerous certifications and advanced training programs, reflecting his commitment to continuous professional development and staying at the forefront of urological advancements.
Read more